MI
CRDL

MMCAP International’s Cardiol Therapeutics CRDL Stock Holding History

MMCAP International’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Buy
15,598,560
+246,243
+2% +$312K 1.4% 16
2026
Q1 		$20.7M Buy
15,352,317
+15,143,367
+7,247% +$15.5M 1.79% 8
2025
Q4 		$199K Sell
208,950
-84,106
-29% -$88.1K 0.02% 125
2025
Q3 		$314K Hold
293,056
– – 0.04% 101
2025
Q2 		$399K Sell
293,056
-489,569
-63% -$570K 0.05% 73
2025
Q1 		$759K Sell
782,625
-13,000
-2% -$16K 0.13% 47
2024
Q4 		$1.02M Hold
795,625
– – 0.15% 47
2024
Q3 		$1.58M Sell
795,625
-128,500
-14% -$267K 0.22% 41
2024
Q2 		$1.87M Sell
924,125
-1,642,000
-64% -$3.48M 0.26% 37
2024
Q1 		$4.64M Sell
2,566,125
-387,175
-13% -$522K 0.6% 24
2023
Q4 		$2.66M Hold
2,953,300
– – 0.49% 23
2023
Q3 		$2.64M Hold
2,953,300
– – 0.76% 17
2023
Q2 		$2.63M Sell
2,953,300
-200,100
-6% -$132K 0.87% 29
2023
Q1 		$1.54M Sell
3,153,400
-200,000
-6% -$118K 0.3% 71
2022
Q4 		$1.71M Hold
3,353,400
– – 0.17% 149
2022
Q3 		$3.45M Hold
3,353,400
– – 0.27% 140
2022
Q2 		$4.43M Buy
3,353,400
+100,000
+3% +$142K 0.35% 110
2022
Q1 		$4.98M Buy
3,253,400
+100,200
+3% +$165K 0.29% 128
2021
Q4 		$5.83M Buy
+3,153,200
New +$8.71M 0.36% 104

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

MMCAP International's CRDL Position: Q2 2026 in Review

MMCAP International increased its Cardiol Therapeutics (CRDL) stake by 1.6% in Q2 2026, buying an estimated $312K and bringing the position to 15,598,560 shares worth $16.5M. The position accounts for 1.4% of the portfolio, ranked #16.

MMCAP International first reported a position in CRDL in Q4 2021 and has held it in 19 quarters since. The position peaked at $20.7M in Q1 2026. 52 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • MMCAP International held 15,598,560 shares of Cardiol Therapeutics worth $16.5M as of Q2 2026.
  • MMCAP International bought 246,243 Cardiol Therapeutics shares in Q2 2026, an estimated $312K.
  • Cardiol Therapeutics made up 1.4% of MMCAP International's portfolio in Q2 2026, its #16 holding.
  • MMCAP International first reported a position in Cardiol Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • MMCAP International's Cardiol Therapeutics position peaked at $20.7M in Q1 2026.
  • 52 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on MMCAP International's 13F filing for Q2 2026, filed 14 Aug 2026.